Company Filing History:
Years Active: 1989
Title: Elmo G Armstrong: Innovator in Immunoassay Technology
Introduction
Elmo G Armstrong is a notable inventor based in Bronx, NY (US). He has made significant contributions to the field of immunoassays, particularly in the detection and measurement of human chorionic gonadotropin (hCG). His innovative work has implications in medical diagnostics and research.
Latest Patents
Elmo G Armstrong holds a patent for an immunoassay designed to detect and measure hCG in various samples. This patent includes an antibody directed to the carboxy terminal portion of the beta subunit of hCG, along with a monoclonal antibody that binds to a different locus on hCG. This unique design allows both antibodies to bind simultaneously, enhancing the assay's effectiveness. The patent is particularly relevant for testing hCG or hCG beta in urine, utilizing a purified, labeled serum-derived antibody and a matrix-bound monoclonal antibody.
Career Highlights
Armstrong is affiliated with Columbia University, where he has contributed to research and development in immunoassay technology. His work has been instrumental in advancing diagnostic methods that are crucial for various medical applications.
Collaborations
Throughout his career, Elmo G Armstrong has collaborated with esteemed colleagues such as Robert E Canfield and Paul H Ehrlich. These partnerships have fostered innovation and have led to significant advancements in the field of immunology.
Conclusion
Elmo G Armstrong's contributions to immunoassay technology exemplify the impact of innovative thinking in medical diagnostics. His patent for detecting hCG showcases his commitment to advancing healthcare solutions.